STYX Human

Serine/Threonine/Tyrosine Interacting Protein Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Structure and Functional Domains

STYX lacks catalytic activity due to a glycine residue at position 120 in its pseudophosphatase domain . Key structural features include:

  • F-box binding motifs: Regions 76FQQ and 142KYR mediate interaction with F-box proteins, though the 76FQQ motif is critical for FBXW7 binding .

  • Nuclear localization: STYX predominantly resides in the nucleus, where it interacts with FBXW7 .

Table 2: FBXW7 Substrates Affected by STYX

SubstrateRole in CancerEffect of STYX OverexpressionSource
c-MycOncogeneStabilized, increased levels
Cyclin ECell cycle progressionStabilized, increased levels
MCL1Anti-apoptoticStabilized, increased levels

Mechanistic Evidence:

  • FRET assays: STYX reduces FRET efficiency between FBXW7 and SKP1, indicating disrupted interaction .

  • Co-IP experiments: STYX immunoprecipitates exclude SKP1, confirming mutually exclusive binding .

Oncogenic Roles in Cancers

STYX overexpression correlates with malignancy across multiple cancers:

Breast Cancer

  • Anti-correlation with FBXW7: High STYX and low FBXW7 levels predict poor prognosis .

  • Therapeutic target: Disrupting STYX-FBXW7 interaction may restore tumor suppression .

Gastric Cancer (GC)

  • H. pylori induction: STYX expression is upregulated via c-Jun in H. pylori-infected cells .

  • FBXO31 interaction: STYX binds FBXO31, stabilizing Cyclin D1 and Snail1, promoting proliferation and metastasis .

Table 3: STYX in Cancer Pathogenesis

Cancer TypeSTYX ExpressionKey MechanismPrognostic ImpactSource
BreastHighFBXW7 inhibitionPoor
GastricHighFBXO31 inhibitionPoor
ColorectalHighFBXW7 inhibitionPoor

Prognostic Biomarker

  • GC survival: STYX knockdown reduces tumor growth and lung metastasis in nude mice .

  • Diagnostic potential: Anti-correlation with FBXW7 in breast cancer offers combinatorial biomarker utility .

Therapeutic Strategies

  • Small-molecule inhibitors: Targeting the STYX-FBXW7 interaction to restore SCF complex activity .

  • Mitochondrial phospholipid modulation: STYX may influence cardiolipin levels via PTPMT1 (requires further validation) .

Future Directions

  1. Isoform-specific targeting: Distinguish STYX from MK-STYX (STYXL1) to avoid off-target effects.

  2. In vivo validation: Test STYX-FBXW7 inhibitors in preclinical models.

  3. Epigenetic regulation: Explore c-Jun-mediated STYX induction in H. pylori-associated GC .

Product Specs

Introduction
Serine/threonine/tyrosine-interacting protein (STYX), a member of the protein-tyrosine phosphatase family, is notable for its lack of catalytic activity as a phosphatase. This is due to the presence of a Gly residue instead of a conserved Cys residue in the dsPTPase catalytic loop. Despite this, STYX retains the ability to bind phosphorylated substrates, potentially shielding them from phosphatases. This suggests a role in spermiogenesis. STYX is considered a potential pseudophosphatase.
Description
Recombinant human STYX, produced in E. coli, is a single, non-glycosylated polypeptide chain. It comprises 247 amino acids (1-223) and has a molecular mass of 28kDa. The protein is fused to a 24 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The STYX solution is provided at a concentration of 0.25mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0), 30% glycerol, 1mM DTT, and 0.1M NaCl.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is greater than 85% as determined by SDS-PAGE analysis.
Synonyms
Serine/threonine/tyrosine-interacting protein, Protein tyrosine phosphatase-like protein, STYX, FLJ42934.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMEDVKL EFPSLPQCKE DAEEWTYPMR REMQEILPGL FLGPYSSAMK SKLPVLQKHG ITHIICIRQN IEANFIKPNF QQLFRYLVLD IADNPVENII RFFPMTKEFI DGSLQMGGKV LVHGNAGISR SAAFVIAYIM ETFGMKYRDA FAYVQERRFC
INPNAGFVHQ LQEYEAIYLA KLTIQMMSPL QIERSLSVHS GTTGSLKRTH EEEDDFGTMQ VATAQNG.

Q&A

What is STYX and how does it function in human cells?

STYX (Serine/threonine/tyrosine-interacting protein) is a catalytically inactive member of the dual-specificity phosphatases (DUSPs) family . Unlike active phosphatases, STYX lacks catalytic activity but retains the ability to bind phosphorylated proteins. Its primary function is as a spatial regulator of ERK signaling pathways. STYX localizes to the nucleus where it competes with nuclear DUSP4 for binding to ERK and acts as a nuclear anchor that regulates ERK nuclear export . This competition and anchoring function allows STYX to modulate ERK signaling without enzymatic activity.

The regulatory function of STYX represents an important paradigm in understanding how pseudophosphatases contribute to cellular signaling networks. While conventional phosphatases remove phosphate groups from their substrates, STYX exerts its influence through protein-protein interactions, particularly by affecting the localization and availability of ERK. This spatial regulation has downstream effects on numerous cellular processes including cell morphology, migration, and differentiation.

How does STYX differ from other members of the phosphatase family?

STYX belongs to the dual-specificity phosphatases (DUSPs) family but is classified as a pseudophosphatase due to its lack of catalytic activity . While conventional DUSPs actively dephosphorylate their substrates to regulate signaling cascades, STYX functions primarily through protein binding and anchoring mechanisms. This fundamental difference reflects an evolutionary adaptation where the protein maintains structural elements for recognition and binding but has lost its catalytic function.

The structural features that distinguish STYX from active phosphatases likely involve specific amino acid substitutions in the catalytic domain that render it enzymatically inactive while preserving its ability to recognize and bind phosphorylated substrates. This unique characteristic enables STYX to function as a regulatory element that modulates signaling through competitive binding rather than enzymatic activity. This mechanism represents an important layer of complexity in cellular signaling networks beyond the traditional kinase-phosphatase paradigm.

What are the primary cellular processes influenced by STYX?

Research has identified several key cellular processes that are regulated by STYX:

  • ERK Signaling Regulation: STYX competes with nuclear DUSP4 for binding to ERK and serves as a nuclear anchor that regulates ERK nuclear export . This spatial regulation affects the duration and location of ERK activity.

  • Golgi Apparatus Morphology: Depletion of STYX causes an ERK-dependent fragmentation of the Golgi apparatus, indicating STYX plays a role in maintaining Golgi integrity .

  • Directional Cell Migration: STYX inhibits Golgi polarization and directional cell migration, processes that determine the invasive and metastatic ability of cancer cells .

  • Cell Differentiation: Overexpression of STYX reduces ERK1/2 activation, thereby blocking PC12 cell differentiation, demonstrating STYX's involvement in cell-fate decisions .

These diverse functions highlight STYX's importance as a multifunctional regulator that influences cellular architecture, motility, and differentiation through its modulation of ERK signaling pathways.

What mechanisms explain STYX's role in regulating ERK signaling dynamics?

STYX regulates ERK signaling through a sophisticated spatial anchoring mechanism that affects both the localization and activity of ERK. Specifically, STYX localizes to the nucleus where it competes with nuclear DUSP4 for binding to ERK, effectively acting as a nuclear anchor that regulates ERK nuclear export . This competition creates a dynamic equilibrium that influences the duration and spatial distribution of ERK activity.

Experimental evidence shows that depletion of STYX increases ERK activity in both the cytosol and nucleus, suggesting that STYX normally serves to restrain ERK signaling . This restraint likely occurs through sequestration of ERK in protein complexes that limit its access to downstream substrates. The mechanism may involve conformational changes in ERK upon STYX binding that affect its interaction with export machinery or other binding partners.

Predictive-model simulations have been used to test several hypotheses for possible modes of STYX action, helping to elucidate these complex regulatory interactions . These computational approaches, combined with experimental validation, have been crucial in developing our current understanding of how this pseudophosphatase functions as a spatial regulator of ERK signaling.

How does STYX influence Golgi apparatus architecture and polarization?

STYX plays a critical role in maintaining Golgi apparatus integrity and polarization through its regulation of ERK signaling. Depletion of STYX causes an ERK-dependent fragmentation of the Golgi apparatus, demonstrating that STYX is necessary for maintaining the structural integrity of this organelle . This fragmentation likely results from dysregulated ERK signaling, which affects the phosphorylation state of Golgi-associated proteins involved in maintaining its architecture.

In migrating cells, the Golgi apparatus typically polarizes toward the leading edge to facilitate directional movement. STYX inhibits this Golgi polarization, consequently affecting directional cell migration . The mechanism likely involves STYX's modulation of ERK signaling pathways that control cytoskeletal rearrangements and Golgi positioning during cell migration.

These findings establish a direct link between STYX-mediated ERK regulation and Golgi organization, highlighting an important pathway through which STYX influences cellular architecture and motility. This connection has significant implications for understanding processes like cancer cell invasion and metastasis, where directional cell migration plays a crucial role.

What is the relationship between STYX and cell-fate decisions in differentiation?

STYX exerts significant influence over cell-fate decisions, particularly in the context of cell differentiation. Research on PC12 cells has shown that overexpression of STYX reduces ERK1/2 activation, thereby blocking PC12 cell differentiation . This finding demonstrates STYX's ability to modulate the threshold for differentiation by regulating ERK activity levels.

The mechanism involves STYX's competition with nuclear DUSP4 for binding to ERK, which affects the duration and intensity of ERK signaling . Since sustained ERK activation is often required for differentiation, STYX-mediated modulation of ERK signaling can determine whether a cell maintains its undifferentiated state or commits to a differentiation pathway.

This regulatory role places STYX at a critical juncture in cell-fate decision networks, where it can influence developmental outcomes by fine-tuning ERK signaling dynamics. Understanding this relationship has important implications for developmental biology and regenerative medicine, where controlled differentiation of cells is a central objective.

What experimental techniques are most effective for studying STYX function?

Studying STYX function effectively requires a combination of molecular, cellular, and computational approaches:

  • Genetic Manipulation: RNA interference techniques to deplete STYX expression and overexpression systems to amplify its effects have proven valuable in understanding its function . These approaches allow researchers to observe the consequences of altered STYX levels on cellular processes.

  • Protein Interaction Studies: Co-immunoprecipitation and proximity ligation assays help identify STYX binding partners, particularly its interactions with ERK and competition with DUSP4 . These techniques provide insight into the molecular mechanisms underlying STYX function.

  • Live Cell Imaging: Fluorescence microscopy techniques to visualize Golgi morphology and cell migration in real-time after STYX manipulation have been instrumental in defining its role in these processes .

  • Predictive Modeling: Computational simulations have been used to test hypotheses about STYX function, providing theoretical frameworks that guide experimental design and interpretation .

  • Phosphorylation Assays: Western blotting and phospho-specific antibodies to monitor ERK activation states in response to STYX manipulation help quantify its effects on signaling pathways .

These complementary approaches provide a comprehensive view of STYX function across multiple levels of biological organization, from molecular interactions to cellular behaviors.

How can researchers effectively design experiments to distinguish direct and indirect effects of STYX?

Distinguishing direct and indirect effects of STYX requires careful experimental design:

  • Temporal Analysis: Monitoring changes in protein phosphorylation and cellular responses at multiple time points after STYX manipulation can help separate immediate (likely direct) from delayed (potentially indirect) effects.

  • Rescue Experiments: After STYX depletion, introduction of wild-type STYX or specific mutants can determine which domains are essential for particular functions, helping to define direct mechanistic relationships .

  • Pathway Inhibition: Using specific inhibitors of ERK or other signaling components in conjunction with STYX manipulation can help determine whether STYX effects require intact signaling through these pathways .

  • In Vitro Binding Assays: Purified protein interaction studies can confirm direct binding between STYX and suspected partners like ERK, establishing the molecular basis for observed cellular effects .

  • Domain Mapping: Mutational analysis of STYX to identify regions critical for its localization, ERK binding, and cellular functions can help establish causality in observed phenotypes .

These approaches collectively provide a framework for distinguishing direct STYX-mediated effects from those that occur as downstream consequences of altered signaling pathways.

What controls are essential in experimental designs studying STYX?

Robust STYX research requires several critical controls:

Including these controls helps ensure that experimental observations genuinely reflect STYX biology rather than technical artifacts or secondary effects unrelated to STYX function.

How should researchers quantify Golgi morphology changes in STYX-related studies?

Quantification of Golgi morphology changes requires systematic approaches:

  • Morphometric Analysis: Measuring parameters such as Golgi area, perimeter, fragmentation index, and circularity provides quantitative metrics of Golgi morphology. These measurements should be performed on multiple cells across independent experiments.

  • Classification Schemes: Developing classification criteria for Golgi morphology (e.g., compact, fragmented, dispersed) allows categorical analysis of large cell populations after STYX manipulation .

  • Automated Image Analysis: Software tools that can segment and analyze Golgi structures in fluorescence images enable high-throughput, objective quantification of morphological changes following STYX depletion or overexpression .

  • Co-localization Metrics: Quantifying the spatial relationship between Golgi markers and other cellular components (e.g., microtubules, ERK) can provide mechanistic insight into how STYX affects Golgi organization .

  • 3D Reconstruction: Confocal z-stack imaging with 3D reconstruction offers more accurate representations of Golgi architecture than single-plane imaging, particularly for complex morphological changes .

What statistical approaches are recommended for analyzing cell migration data in STYX experiments?

Analysis of cell migration in STYX experiments requires specialized statistical approaches:

  • Directional Statistics: Circular statistics methods are appropriate for analyzing directional data, such as the orientation of cell movement relative to a stimulus or the Golgi polarization angle .

  • Migration Parameters: Quantification should include multiple parameters such as velocity, directionality ratio (displacement/track length), mean square displacement, and persistence time to capture different aspects of migration behavior .

  • Population Analysis: Examining the distribution of migration parameters across cell populations, rather than just mean values, can reveal subpopulations with distinct responses to STYX manipulation .

  • Temporal Analysis: Time-resolved analysis of migration parameters can distinguish effects on initiation versus maintenance of directional movement, providing insight into when STYX exerts its influence .

  • Multivariate Analysis: Techniques such as principal component analysis can help identify patterns and correlations between multiple migration parameters and STYX-dependent cellular changes .

What are the key challenges in understanding STYX's role in human disease?

Understanding STYX's role in human disease presents several significant challenges:

  • Expression Heterogeneity: STYX expression likely varies across tissues and disease states, requiring comprehensive profiling to identify relevant contexts for functional studies.

  • Redundancy: Potential functional redundancy with other pseudophosphatases or ERK regulatory proteins may mask phenotypes in single-gene studies, necessitating combinatorial approaches.

  • Context Dependence: STYX's effects on ERK signaling may vary depending on cell type, activation state, and the presence of other regulatory factors, creating complexity in determining its role in disease pathogenesis .

  • Technical Limitations: Studying endogenous STYX interactions in primary human tissues remains technically challenging, limiting our understanding of its native function in disease-relevant contexts.

  • Translational Barriers: Developing therapeutic strategies targeting a protein-protein interaction mediator like STYX presents pharmaceutical challenges different from targeting enzymatic activities.

Addressing these challenges will require integrated approaches combining clinical observations, patient-derived samples, and mechanistic studies to establish STYX's contribution to human disease pathogenesis and potential as a therapeutic target.

How can computational modeling enhance our understanding of STYX's regulatory functions?

Computational modeling offers powerful approaches to understanding STYX's complex regulatory functions:

  • Systems Biology Models: Mathematical modeling of ERK signaling networks incorporating STYX as a spatial regulator can predict system behaviors under various conditions and generate testable hypotheses .

  • Molecular Dynamics Simulations: Atomistic simulations of STYX-ERK interactions can reveal the structural basis for binding specificity and competition with DUSP4, informing rational design of modulators .

  • Agent-Based Models: Simulations of cell migration incorporating STYX-dependent regulation of Golgi polarization and cytoskeletal dynamics can connect molecular mechanisms to emergent cellular behaviors .

  • Predictive-Model Simulations: As already successfully employed in STYX research, these models test multiple hypotheses about STYX's mode of action and predict outcomes of experimental manipulations .

  • Multi-scale Modeling: Integrating molecular, cellular, and tissue-level models can bridge scales to understand how STYX-mediated effects on individual cells translate to tissue-level phenotypes.

These computational approaches complement experimental studies by generating predictions, testing the plausibility of hypothesized mechanisms, and revealing emergent properties of complex signaling networks influenced by STYX.

What are promising future research directions for STYX investigation?

Several promising directions for future STYX research include:

  • Structural Biology: Determining the crystal structure of STYX in complex with ERK would provide crucial insights into the molecular basis of their interaction and facilitate structure-based drug design.

  • Single-Cell Analysis: Investigating cell-to-cell variability in STYX expression and its correlation with ERK activity and cell fate decisions could reveal how signaling heterogeneity influences population-level outcomes .

  • Disease Relevance: Exploring STYX's role in cancer cell invasion and metastasis, given its effects on directional cell migration, could identify new therapeutic targets for preventing cancer progression .

  • Developmental Biology: Investigating STYX's role in development, particularly in contexts where ERK signaling drives cell differentiation, could reveal new mechanisms of developmental regulation .

  • Therapeutic Targeting: Developing small molecules or peptides that modulate STYX-ERK interactions could provide new tools for manipulating ERK signaling in research and potentially therapeutic contexts.

These research directions build on our current understanding of STYX while expanding into new areas with potential clinical and biological significance, promising to further illuminate the role of this pseudophosphatase in human biology and disease.

Product Science Overview

Introduction

Serine/Threonine/Tyrosine Interacting Protein (STYIP) is a multifunctional protein that plays a crucial role in various cellular processes. It is involved in the regulation of cell signaling pathways, particularly those related to phosphorylation, which is a key mechanism for controlling protein activity and function. The human recombinant form of this protein is produced through recombinant DNA technology, allowing for its use in research and therapeutic applications.

Structure and Function

STYIP is characterized by its ability to interact with serine, threonine, and tyrosine residues on target proteins. This interaction is essential for the regulation of protein phosphorylation, a process that involves the addition or removal of phosphate groups to or from proteins. Phosphorylation can activate or deactivate proteins, thereby influencing various cellular activities such as cell growth, differentiation, and apoptosis.

Preparation Methods

The production of human recombinant STYIP involves several steps:

  1. Gene Cloning: The gene encoding STYIP is cloned into an expression vector, which is a DNA molecule used to introduce the gene into host cells.
  2. Transformation: The expression vector is introduced into host cells, typically bacteria or yeast, through a process called transformation.
  3. Protein Expression: The host cells are cultured under conditions that promote the expression of the STYIP gene, leading to the production of the protein.
  4. Purification: The recombinant protein is purified from the host cells using techniques such as affinity chromatography, which isolates the protein based on its specific binding properties.
Chemical Reactions and Analysis

STYIP is involved in various chemical reactions related to protein phosphorylation. It acts as a kinase, transferring phosphate groups from ATP to specific serine, threonine, or tyrosine residues on target proteins. This phosphorylation can alter the activity, localization, and stability of the target proteins, thereby modulating cellular signaling pathways.

Applications

The human recombinant form of STYIP is widely used in research to study the mechanisms of protein phosphorylation and its role in cellular processes. It is also used in drug development to identify potential therapeutic targets for diseases related to dysregulated phosphorylation, such as cancer and neurodegenerative disorders.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.